Cargando…

Evaluating an automated machine learning model that predicts visual acuity outcomes in patients with neovascular age-related macular degeneration

PURPOSE: Neovascular age-related macular degeneration (nAMD) is a major global cause of blindness. Whilst anti-vascular endothelial growth factor (anti-VEGF) treatment is effective, response varies considerably between individuals. Thus, patients face substantial uncertainty regarding their future a...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbas, Abdallah, O’Byrne, Ciara, Fu, Dun Jack, Moraes, Gabriella, Balaskas, Konstantinos, Struyven, Robbert, Beqiri, Sara, Wagner, Siegfried K., Korot, Edward, Keane, Pearse A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325856/
https://www.ncbi.nlm.nih.gov/pubmed/35122132
http://dx.doi.org/10.1007/s00417-021-05544-y
_version_ 1784757150615076864
author Abbas, Abdallah
O’Byrne, Ciara
Fu, Dun Jack
Moraes, Gabriella
Balaskas, Konstantinos
Struyven, Robbert
Beqiri, Sara
Wagner, Siegfried K.
Korot, Edward
Keane, Pearse A.
author_facet Abbas, Abdallah
O’Byrne, Ciara
Fu, Dun Jack
Moraes, Gabriella
Balaskas, Konstantinos
Struyven, Robbert
Beqiri, Sara
Wagner, Siegfried K.
Korot, Edward
Keane, Pearse A.
author_sort Abbas, Abdallah
collection PubMed
description PURPOSE: Neovascular age-related macular degeneration (nAMD) is a major global cause of blindness. Whilst anti-vascular endothelial growth factor (anti-VEGF) treatment is effective, response varies considerably between individuals. Thus, patients face substantial uncertainty regarding their future ability to perform daily tasks. In this study, we evaluate the performance of an automated machine learning (AutoML) model which predicts visual acuity (VA) outcomes in patients receiving treatment for nAMD, in comparison to a manually coded model built using the same dataset. Furthermore, we evaluate model performance across ethnic groups and analyse how the models reach their predictions. METHODS: Binary classification models were trained to predict whether patients’ VA would be ‘Above’ or ‘Below’ a score of 70 one year after initiating treatment, measured using the Early Treatment Diabetic Retinopathy Study (ETDRS) chart. The AutoML model was built using the Google Cloud Platform, whilst the bespoke model was trained using an XGBoost framework. Models were compared and analysed using the What-if Tool (WIT), a novel model-agnostic interpretability tool. RESULTS: Our study included 1631 eyes from patients attending Moorfields Eye Hospital. The AutoML model (area under the curve [AUC], 0.849) achieved a highly similar performance to the XGBoost model (AUC, 0.847). Using the WIT, we found that the models over-predicted negative outcomes in Asian patients and performed worse in those with an ethnic category of Other. Baseline VA, age and ethnicity were the most important determinants of model predictions. Partial dependence plot analysis revealed a sigmoidal relationship between baseline VA and the probability of an outcome of ‘Above’. CONCLUSION: We have described and validated an AutoML-WIT pipeline which enables clinicians with minimal coding skills to match the performance of a state-of-the-art algorithm and obtain explainable predictions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00417-021-05544-y.
format Online
Article
Text
id pubmed-9325856
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-93258562022-07-28 Evaluating an automated machine learning model that predicts visual acuity outcomes in patients with neovascular age-related macular degeneration Abbas, Abdallah O’Byrne, Ciara Fu, Dun Jack Moraes, Gabriella Balaskas, Konstantinos Struyven, Robbert Beqiri, Sara Wagner, Siegfried K. Korot, Edward Keane, Pearse A. Graefes Arch Clin Exp Ophthalmol Retinal Disorders PURPOSE: Neovascular age-related macular degeneration (nAMD) is a major global cause of blindness. Whilst anti-vascular endothelial growth factor (anti-VEGF) treatment is effective, response varies considerably between individuals. Thus, patients face substantial uncertainty regarding their future ability to perform daily tasks. In this study, we evaluate the performance of an automated machine learning (AutoML) model which predicts visual acuity (VA) outcomes in patients receiving treatment for nAMD, in comparison to a manually coded model built using the same dataset. Furthermore, we evaluate model performance across ethnic groups and analyse how the models reach their predictions. METHODS: Binary classification models were trained to predict whether patients’ VA would be ‘Above’ or ‘Below’ a score of 70 one year after initiating treatment, measured using the Early Treatment Diabetic Retinopathy Study (ETDRS) chart. The AutoML model was built using the Google Cloud Platform, whilst the bespoke model was trained using an XGBoost framework. Models were compared and analysed using the What-if Tool (WIT), a novel model-agnostic interpretability tool. RESULTS: Our study included 1631 eyes from patients attending Moorfields Eye Hospital. The AutoML model (area under the curve [AUC], 0.849) achieved a highly similar performance to the XGBoost model (AUC, 0.847). Using the WIT, we found that the models over-predicted negative outcomes in Asian patients and performed worse in those with an ethnic category of Other. Baseline VA, age and ethnicity were the most important determinants of model predictions. Partial dependence plot analysis revealed a sigmoidal relationship between baseline VA and the probability of an outcome of ‘Above’. CONCLUSION: We have described and validated an AutoML-WIT pipeline which enables clinicians with minimal coding skills to match the performance of a state-of-the-art algorithm and obtain explainable predictions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00417-021-05544-y. Springer Berlin Heidelberg 2022-02-05 2022 /pmc/articles/PMC9325856/ /pubmed/35122132 http://dx.doi.org/10.1007/s00417-021-05544-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Retinal Disorders
Abbas, Abdallah
O’Byrne, Ciara
Fu, Dun Jack
Moraes, Gabriella
Balaskas, Konstantinos
Struyven, Robbert
Beqiri, Sara
Wagner, Siegfried K.
Korot, Edward
Keane, Pearse A.
Evaluating an automated machine learning model that predicts visual acuity outcomes in patients with neovascular age-related macular degeneration
title Evaluating an automated machine learning model that predicts visual acuity outcomes in patients with neovascular age-related macular degeneration
title_full Evaluating an automated machine learning model that predicts visual acuity outcomes in patients with neovascular age-related macular degeneration
title_fullStr Evaluating an automated machine learning model that predicts visual acuity outcomes in patients with neovascular age-related macular degeneration
title_full_unstemmed Evaluating an automated machine learning model that predicts visual acuity outcomes in patients with neovascular age-related macular degeneration
title_short Evaluating an automated machine learning model that predicts visual acuity outcomes in patients with neovascular age-related macular degeneration
title_sort evaluating an automated machine learning model that predicts visual acuity outcomes in patients with neovascular age-related macular degeneration
topic Retinal Disorders
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325856/
https://www.ncbi.nlm.nih.gov/pubmed/35122132
http://dx.doi.org/10.1007/s00417-021-05544-y
work_keys_str_mv AT abbasabdallah evaluatinganautomatedmachinelearningmodelthatpredictsvisualacuityoutcomesinpatientswithneovascularagerelatedmaculardegeneration
AT obyrneciara evaluatinganautomatedmachinelearningmodelthatpredictsvisualacuityoutcomesinpatientswithneovascularagerelatedmaculardegeneration
AT fudunjack evaluatinganautomatedmachinelearningmodelthatpredictsvisualacuityoutcomesinpatientswithneovascularagerelatedmaculardegeneration
AT moraesgabriella evaluatinganautomatedmachinelearningmodelthatpredictsvisualacuityoutcomesinpatientswithneovascularagerelatedmaculardegeneration
AT balaskaskonstantinos evaluatinganautomatedmachinelearningmodelthatpredictsvisualacuityoutcomesinpatientswithneovascularagerelatedmaculardegeneration
AT struyvenrobbert evaluatinganautomatedmachinelearningmodelthatpredictsvisualacuityoutcomesinpatientswithneovascularagerelatedmaculardegeneration
AT beqirisara evaluatinganautomatedmachinelearningmodelthatpredictsvisualacuityoutcomesinpatientswithneovascularagerelatedmaculardegeneration
AT wagnersiegfriedk evaluatinganautomatedmachinelearningmodelthatpredictsvisualacuityoutcomesinpatientswithneovascularagerelatedmaculardegeneration
AT korotedward evaluatinganautomatedmachinelearningmodelthatpredictsvisualacuityoutcomesinpatientswithneovascularagerelatedmaculardegeneration
AT keanepearsea evaluatinganautomatedmachinelearningmodelthatpredictsvisualacuityoutcomesinpatientswithneovascularagerelatedmaculardegeneration